Please login to the form below

Not currently logged in


This page shows the latest Gazyvaro news and features for those working in and with pharma, biotech and healthcare.

NICE backs Roche’s Gazyvaro after initial rejection

NICE backs Roche’s Gazyvaro after initial rejection

NICE backs Roche’ s Gazyvaro after initial rejection. An undisclosed discount swayed the cost-effectiveness body. ... The Scottish Medicines Consortium (SMC) turned down Gazyvaro as a first-line option with chemotherapy last month.

Latest news

More from news
Approximately 12 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....